latest news releases from the newsroom
Agent155 Media Group Inc.
Agent155 Media Group Launches New York City Subway Ad Campaign
SAN DIEGO, Jan. 3, 2005 (PRIMEZONE) -- Agent155 Media Group, Inc. (Pink Sheets:AGMG), A provider of multi-media content management tools providing exposure, networking and collaboration opportunities to models, performers, artists, athletes, musicians, filmmakers and agencies worldwide, today announced it will implement an outdoor ad campaign mid-January through Viacom (NYSE:VIA) targeting commuters utilizing the New York City subway system.
Georges Jacobs Succeeds Gui de Vaucleroy as Chairman of Delhaize Group
BRUSSELS, Belgium, Jan. 3, 2005 (PRIMEZONE) -- Delhaize Group (Euronext Brussels:DELB) (NYSE:DEG), the Belgian international food retailer, announced today that, as of January 1, 2005 Georges Jacobs became Chairman of its Board of Directors. Mr. Jacobs succeeds, as planned, Gui de Vaucleroy, who reached the retirement age to serve as Chairman of the Board of Delhaize Group.
Murray, Frank & Sailer LLP
Investor Reminder: Deadline to Join Shareholder Class Action Against UTStarcom, Inc. is January 14, 2005 -- UTSI
NEW YORK, Dec. 31, 2004 (PRIMEZONE) -- Murray, Frank & Sailer LLP has filed a class action lawsuit on behalf of purchasers of the securities of UTStarcom, Inc. ("UTStarcom" or the "Company") (Nasdaq:UTSI) between April 16, 2003 and September 20, 2004, inclusive (the "Class Period").
Scott + Scott, LLC's Connecticut Office Files Securities Class Action Against Pfizer in Connecticut Federal District Court - PFE
COLCHESTER, Conn., Dec. 31, 2004 (PRIMEZONE) -- Scott + Scott, LLC (e-mail: email@example.com), has filed a class action lawsuit against Pfizer, Inc. (NYSE:PFE) in the United States District Court for the District of Connecticut on behalf of those who purchased or acquired Pfizer, Inc. securities from October 31, 2000 to December 16, 2004 (the "Class Period"). The lawsuit against Pfizer alleges the Company violated the federal securities laws by issuing materially false and misleading statements during the Class Period. New prescriptions for Pfizer's pain killer Celebrex(r), the leader in a class of drugs called cox-2 inhibitors, plummeted 56% last week just after a federal study found a link between Celebrex(r) and a heightened risk of heart attacks and strokes. This lawsuit also names individual defendants Henry A. McKinnell, who was Chairman of the Board and Chief Executive Officer and John L. LaMattina, who was President of Gobal Research and Develpoment of Pfizer. Specifically, as stated in the complaint, LaMattina was responsible for scientific reporting concerning the safety of Celebrex(r).
Eastmain Resources Inc.
Eastmain Resources Inc.: $3 Million Private Placement Completed
TORONTO, Ontario, Dec. 31, 2004 (PRIMEZONE) -- Eastmain Resources Inc. (TSX:ER) disclosed today that the private placement announced on December 12, 2004 has been fully subscribed. The offering consisted of 4,300,000 flow-through units at $0.70 per unit for aggregate gross proceeds of $3,010,000. Each unit consisted of one common share and one-half of one common share purchase warrant. Each whole warrant will entitle the holder to purchase one common share at a price of $0.85 per share for a period of 12 months following the closing of the offering.
StockPickReport: "Stock Picks for Friday"
SHREVEPORT, La., Dec. 31, 2004 (PRIMEZONE) -- StockPickReport.Com (http://www.stockpickreport.com - the web's only non-mainstream stock rating service), rates Nextel Communications Inc, Red Hat Inc, Research In Motion Ltd, BearingPoint Inc